ストックスクリーナーアプリを入手
12.55
2.70%
0.33
アフターアワーズ：
12.54
-0.01
-0.08%
前日終値:
$12.22
開ける：
$12.21
24時間の取引高:
87,140
Relative Volume:
0.39
時価総額：
$424.97M
収益：
$59,000
当期純損益:
$-21.81M
株価収益率:
-1.1459
EPS:
-10.9518
ネットキャッシュフロー:
$-18.07M
1週間 パフォーマンス:
+7.91%
1か月 パフォーマンス:
-4.20%
6か月 パフォーマンス:
+12.25%
1年 パフォーマンス:
+16.42%
1日の値動き範囲:
$11.91
$12.57
1週間の範囲:
$11.55
$13.11
52週間の値動き範囲:
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
BNTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
12.55 | 413.80M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-09-12 | 開始されました | Guggenheim | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-06-13 | 開始されました | Piper Sandler | Overweight |
| 2020-10-05 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-02-26 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-31 | 繰り返されました | Maxim Group | Buy |
| 2015-09-16 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Benitec Biopharma Inc (BNTC) 最新ニュース
Understanding Momentum Shifts in (BNTC) - Stock Traders Daily
Analyst Downgrade: Should I average down on GBTG stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn
Hedge Fund Bets: Is Benitec Biopharma Inc forming a double bottomJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest - MarketBeat
Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily
Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada
Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com Canada
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target By Investing.com - Investing.com South Africa
Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus
Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - Sahm
Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - ulpravda.ru
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com
Published on: 2026-01-09 06:38:29 - Улправда
Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - Улправда
Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 105.93% Potential Upside in Genetic Medicine - DirectorsTalk Interviews
Suvretta Capital Management, LLC Acquires Additional Shares in B - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 77,387 Shares of Stock - Defense World
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com South Africa
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Wall Street analysts predict an 87.48% upside in Benitec Biopharma (BNTC): Here's what you should know - MSN
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares of Stock - Defense World
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 By Investing.com - Investing.com UK
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares - MarketBeat
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock - MarketBeat
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 - Investing.com
Why Benitec Biopharma Inc. stock attracts global investorsQuarterly Market Review & Community Verified Trade Alerts - Улправда
Benitec Biopharma Inc (BNTC) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):